$2.6M Capped eSense-Lab Signs US$600k Revenue Deal
Jun 19, 2020
Backed by a new leadership team, ASX-listed biotech junior, eSense-Lab (ASX:ESE) is implementing a new business model that sees it enter joint venture (JV) agreements to quickly reach multiple revenue-generating markets.
Game Changer? ASX Stock Reverse Engineering Cannabis Plants
Jul 2, 2019
Who is the ASX company with transforming qualities that could completely disrupt the cannabis and CBD markets?